Insider Transactions Reported by 19 Insiders of Sage Therapeutics, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 06 Mar 2025

Sage Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JEFFREY M. JONAS Director $2,467,446 10 Jun 2024
KIMI IGUCHI CFO & Treasurer $729,389 05 Aug 2024
Stephen Kanes Chief Medical Officer $259,586 19 Oct 2021
Laura Gault Chief Medical Officer $248,780 13 Feb 2025
Anne Marie Cook SVP, GC & Secretary $215,398 05 Aug 2024
Elizabeth Barrett Director $57,810 10 Jun 2024
Christopher Benecchi Chief Operating Officer $0 31 Jul 2025
JAMES M. FRATES Director $0 31 Jul 2025
Gregory L. Shiferman Senior Vice President, General Counsel and Secretary $0 31 Jul 2025
Michael C. Quirk Chief Scientific Officer and Interim Head of R&D $0 31 Jul 2025
Barry E. Greene President and CEO, Director $0 31 Jul 2025
Elizabeth A. Barrett Director $0 31 Jul 2025
George Golumbeski Director $0 31 Jul 2025
Geno J. Germano Director 31 Jul 2025
KEVIN P. STARR Director 15 Jun 2023
Albert Robichaud Chief Scientific Officer 13 Feb 2023
STEVEN M. PAUL Director 03 Jan 2024
Jessica Federer Director 31 Jul 2025
MICHAEL F. COLA Director 31 Jul 2025

Recent Insider Transactions by Companies or Individuals for Sage Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.